sábado, 22 de enero de 2011

FDA panel sees promise in Alzheimers imaging drug

-- A federal panel of medical experts said Thursday a first-of-a-kind imaging chemical designed to help screen for Alzheimer's disease could be useful pending additional study and training for physicians.

Via: http://www.physorg.com

No hay comentarios: